First Time Loading...

Charles River Laboratories International Inc
NYSE:CRL

Watchlist Manager
Charles River Laboratories International Inc Logo
Charles River Laboratories International Inc
NYSE:CRL
Watchlist
Price: 232.77 USD 1.91% Market Closed
Updated: May 14, 2024

Operating Margin
Charles River Laboratories International Inc

15.3%
Current
17%
Average
3.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
15.3%
=
Operating Profit
627.2m
/
Revenue
4.1B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Charles River Laboratories International Inc
NYSE:CRL
11.9B USD
15%
US
Thermo Fisher Scientific Inc
NYSE:TMO
228.1B USD
17%
US
Danaher Corp
NYSE:DHR
190.2B USD
22%
US
Agilent Technologies Inc
NYSE:A
44.2B USD
19%
US
IQVIA Holdings Inc
NYSE:IQV
41.7B USD
14%
KR
Samsung Biologics Co Ltd
KRX:207940
55.6T KRW
30%
CH
Lonza Group AG
SIX:LONN
36.7B CHF
20%
US
Mettler-Toledo International Inc
NYSE:MTD
31.9B USD
29%
IE
ICON PLC
NASDAQ:ICLR
26B USD
13%
US
West Pharmaceutical Services Inc
NYSE:WST
25.6B USD
23%
US
Waters Corp
NYSE:WAT
21.2B USD
27%
Charles River Laboratories International Inc
NYSE:CRL
Country US
Market Cap 11.9B USD
Operating Margin
15%
Thermo Fisher Scientific Inc
NYSE:TMO
Country US
Market Cap 228.1B USD
Operating Margin
17%
Danaher Corp
NYSE:DHR
Country US
Market Cap 190.2B USD
Operating Margin
22%
Agilent Technologies Inc
NYSE:A
Country US
Market Cap 44.2B USD
Operating Margin
19%
IQVIA Holdings Inc
NYSE:IQV
Country US
Market Cap 41.7B USD
Operating Margin
14%
Samsung Biologics Co Ltd
KRX:207940
Country KR
Market Cap 55.6T KRW
Operating Margin
30%
Lonza Group AG
SIX:LONN
Country CH
Market Cap 36.7B CHF
Operating Margin
20%
Mettler-Toledo International Inc
NYSE:MTD
Country US
Market Cap 31.9B USD
Operating Margin
29%
ICON PLC
NASDAQ:ICLR
Country IE
Market Cap 26B USD
Operating Margin
13%
West Pharmaceutical Services Inc
NYSE:WST
Country US
Market Cap 25.6B USD
Operating Margin
23%
Waters Corp
NYSE:WAT
Country US
Market Cap 21.2B USD
Operating Margin
27%

Profitability Report

View the profitability report to see the full profitability analysis for Charles River Laboratories International Inc.

Full Profitability Report

See Also

Summary
CRL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRL stock valuation using valuation multiples.
Wall Street Estimates
CRL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
15.3%
=
Operating Profit
627.2m
/
Revenue
4.1B
What is the Operating Margin of Charles River Laboratories International Inc?

Based on Charles River Laboratories International Inc's most recent financial statements, the company has Operating Margin of 15.3%.

ALPHA SPREAD
Join more than 137,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.